Immuno-PET Molecular Imaging of RANKL in Cancer

SIMPLE SUMMARY: Receptor activator of the nuclear factor kappa B ligand (RANKL) has been recently identified as a target of interest in the tumor microenvironment (TME), specifically in facilitating an immunosuppressive environment and subsequent resistance to immunotherapy. However, assessment of R...

Descripción completa

Detalles Bibliográficos
Autores principales: Dewulf, Jonatan, Vangestel, Christel, Verhoeven, Yannick, De Waele, Jorrit, Zwaenepoel, Karen, van Dam, Peter A., Elvas, Filipe, Van den Wyngaert, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124205/
https://www.ncbi.nlm.nih.gov/pubmed/33946410
http://dx.doi.org/10.3390/cancers13092166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124205/
https://www.ncbi.nlm.nih.gov/pubmed/33946410
http://dx.doi.org/10.3390/cancers13092166

Ejemplares similares